Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Hafron

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
The Prostate|November 7, 2022
Impact of the bladder detrusor muscular ring on lower urinary tract symptoms due to benign prostatic hyperplasia: A quantitative MRI analysisKiran R Nandalur, David Walker, Hong Ye, et al.
The Oncologist|March 30, 2023
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study ResultsKim N Chi, Neil Fleshner, Vincenzo Emanuele Chiuri, et al.
Cancer|February 6, 2026
Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomyBrian R Lane, Patrick Lewicki, Sabrina L Noyes, et al.
BJU International|October 10, 2020
Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I studyShiva M Nair, Gencay Hatiboglu, James Relle, et al.
Research and Reports in Urology|April 28, 2015
One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detectionRima Tinawi-Aljundi, Lauren King, Shannon T Knuth, et al.
The Journal of Urology|June 25, 2024
Association of Baseline Magnetic Resonance Imaging Prostate Imaging Reporting and Data System Score With Prostate Cancer Active Surveillance Early Biopsy Reclassification: Data From the Michigan Urological Surgery Improvement Collaborative (MUSIC)Kiran R Nandalur, Chen Shen, Lili Zhao, et al.
The Prostate|March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelinesNeal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
Prostate Cancer and Prostatic Diseases|September 5, 2024
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testingLauren Lenz, Wyatt Clegg, Diana Iliev, et al.
The Journal of Urology|December 26, 2023
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk StratificationLeander Van Neste, Ricardo Henao, Kirk J Wojno, et al.
European Urology|January 19, 2016
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical TrialJoseph L Chin, Michele Billia, James Relle, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The Prostate|November 7, 2022
Impact of the bladder detrusor muscular ring on lower urinary tract symptoms due to benign prostatic hyperplasia: A quantitative MRI analysisKiran R Nandalur, David Walker, Hong Ye, et al.
The Oncologist|March 30, 2023
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study ResultsKim N Chi, Neil Fleshner, Vincenzo Emanuele Chiuri, et al.
Cancer|February 6, 2026
Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomyBrian R Lane, Patrick Lewicki, Sabrina L Noyes, et al.
BJU International|October 10, 2020
Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I studyShiva M Nair, Gencay Hatiboglu, James Relle, et al.
Research and Reports in Urology|April 28, 2015
One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detectionRima Tinawi-Aljundi, Lauren King, Shannon T Knuth, et al.
The Journal of Urology|June 25, 2024
Association of Baseline Magnetic Resonance Imaging Prostate Imaging Reporting and Data System Score With Prostate Cancer Active Surveillance Early Biopsy Reclassification: Data From the Michigan Urological Surgery Improvement Collaborative (MUSIC)Kiran R Nandalur, Chen Shen, Lili Zhao, et al.
The Prostate|March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelinesNeal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
Prostate Cancer and Prostatic Diseases|September 5, 2024
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testingLauren Lenz, Wyatt Clegg, Diana Iliev, et al.
The Journal of Urology|December 26, 2023
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk StratificationLeander Van Neste, Ricardo Henao, Kirk J Wojno, et al.
European Urology|January 19, 2016
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical TrialJoseph L Chin, Michele Billia, James Relle, et al.
Pageof 8